Diabetic nephropathy (DN) is a common microvascular complication of diabetes mellitus
(DM), which can lead to renal failure in diabetic patients. At present, the first-line drugs for …

Diabetic nephropathy (DN), the leading cause of end-stage renal disease, is the most
significant microvascular complication of diabetes and poses a severe public health concern …

Background LncRNA AK044604 (regulator of insulin sensitivity and autophagy, Risa) and
autophagy-related factors Sirt1 and GSK3β play important roles in diabetic nephropathy …

Diabetic kidney disease (DKD) is the main cause of end-stage renal disease worldwide, and
there is a lack of effective treatment strategies. Autophagy is a highly conserved lysosomal …

Sirtuins are a family of NAD+ III-dependent histone deacetylases that consists of seven
family members, Sirt1-Sirt7, which regulate various signalling pathways and are involved in …

Objective In this study, we used network pharmacology to explore the possible therapeutic
mechanism underlying the treatment of diabetic nephropathy with Yishen capsules. Methods …

Purpose Using network pharmacology and molecular docking to explore the mechanism of
Yishen Capsule in the treatment of diabetic nephropathy. Materials and Methods Active …

Angiogenesis plays an important role in tissue development and repair, and how to regulate
angiogenesis effectively is a widely studied problem in the biomedical field. In recent years …

Background: Diabetic nephropathy (DN) is a widespread diabetic complication and a major
cause of terminal kidney disease. There is no doubt that DN is a chronic disease that …

Diabetic nephropathy (DN) is a chronic kidney disease that develops in patients with
diabetes mellitus (DM). Renal dysfunction and persistent proteinuria are the main clinical …